Macroaxis considers BioTime to be unknown risk. BioTime secures Sharpe Ratio (or Efficiency) of -0.3567 which signifies that BioTime had -0.3567% of return per unit of risk over the last 2 months. Macroaxis philosophy towards foreseeing risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. BioTime exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm BioTime Risk Adjusted Performance of
(0.35) and Mean Deviation of 3.27 to double-check risk estimate we provide.
|Horizon||30 Days Login to change|
BioTime Market Sensitivity
|As returns on market increase, BioTime returns are expected to increase less than the market. However during bear market, the loss on holding BioTime will be expected to be smaller as well.2 Months Beta |Analyze BioTime Demand TrendCheck current 30 days BioTime correlation with market (DOW)|
β = 0.3072
BioTime Central Daily Price Deviation
BioTime Technical Analysis
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
BioTime Projected Return Density Against MarketAssuming 30 trading days horizon, BioTime has beta of 0.3072 . This suggests as returns on market go up, BioTime average returns are expected to increase less than the benchmark. However during bear market, the loss on holding BioTime will be expected to be much smaller as well. Additionally, BioTime has a negative alpha implying that the risk taken by holding this equity is not justified. The company is significantly underperforming DOW
Predicted Return Density
Assuming 30 trading days horizon, the coefficient of variation of BioTime is -280.37. The daily returns are destributed with a variance of 16.75 and standard deviation of 4.09. The mean deviation of BioTime is currently at 3.18. For similar time horizon, the selected benchmark (DOW) has volatility of 1.29
|Alpha over DOW||=||1.12|
|Beta against DOW||=||0.31|
BioTime Return VolatilityBioTime assumes 4.0921% volatility of returns over the 30 days investment horizon. DOW inherits 1.2955% risk (volatility on return distribution) over the 30 days horizon.
BioTime has a volatility of 4.09 and is 3.15 times more volatile than DOW. 37% of all equities and portfolios are less risky than BioTime. Compared to the overall equity markets, volatility of historical daily returns of BioTime is lower than 37 (%) of all global equities and portfolios over the last 30 days. Use BioTime to protect against small markets fluctuations. The stock experiences unexpected downward movement. The market is reacting to new fundamentals. Check odds of BioTime to be traded at S451.01 in 30 days. As returns on market increase, BioTime returns are expected to increase less than the market. However during bear market, the loss on holding BioTime will be expected to be smaller as well.
BioTime correlation with market